TILANX Trademark

Trademark Overview

On Monday, February 22, 2010, a trademark application was filed for TILANX with the United States Patent and Trademark Office. The USPTO has given the TILANX trademark a serial number of 77941435. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 25, 2013. This trademark is owned by Pfizer Inc.. The TILANX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
tilanx

General Information

Serial Number77941435
Word MarkTILANX
Filing DateMonday, February 22, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 25, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 30, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, November 25, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 25, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2013EXTENSION 5 GRANTED
Monday, April 15, 2013EXTENSION 5 FILED
Monday, April 15, 2013TEAS EXTENSION RECEIVED
Wednesday, November 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 27, 2012EXTENSION 4 GRANTED
Friday, October 19, 2012EXTENSION 4 FILED
Monday, November 26, 2012NOTICE OF REVIVAL - E-MAILED
Monday, November 26, 2012EXTENSION RECEIVED WITH TEAS PETITION
Monday, November 26, 2012PETITION TO REVIVE-GRANTED
Monday, November 26, 2012TEAS PETITION TO REVIVE RECEIVED
Monday, November 19, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 19, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 20, 2012EXTENSION 3 GRANTED
Tuesday, April 17, 2012EXTENSION 3 FILED
Tuesday, April 17, 2012TEAS EXTENSION RECEIVED
Thursday, October 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2011EXTENSION 2 GRANTED
Friday, October 7, 2011EXTENSION 2 FILED
Friday, October 7, 2011TEAS EXTENSION RECEIVED
Wednesday, April 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 12, 2011EXTENSION 1 GRANTED
Thursday, April 7, 2011EXTENSION 1 FILED
Monday, April 11, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 7, 2011TEAS EXTENSION RECEIVED
Tuesday, October 19, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 24, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2010PUBLISHED FOR OPPOSITION
Saturday, July 17, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, July 17, 2010ASSIGNED TO LIE
Wednesday, June 30, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 30, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 30, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 30, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 25, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 25, 2010NON-FINAL ACTION E-MAILED
Tuesday, May 25, 2010NON-FINAL ACTION WRITTEN
Tuesday, May 25, 2010REMOVED FROM TEAS PLUS
Thursday, May 20, 2010ASSIGNED TO EXAMINER
Friday, February 26, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 25, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

tilanx preparations pharmaceutical treatment dysfunction disorders erectile viral urological sexual diseases